Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate |
2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106146482-B |
titleOfInvention |
Bruton's tyrosine kinase inhibitor |
abstract |
The present invention provides Burton's tyrosine kinase inhibitors. Specifically, through extensive and in-depth research in the present invention, a class of compounds that can be used as Btk inhibitors is obtained. The experimental results show that the compounds are effective against Btk Has a good inhibitory effect. The present invention also provides a preparation method of the above compound and its use in preparing a medicine. |
priorityDate |
2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |